AU4065301A - Novel galenical form for oral administration with prolonged release of molsidomine - Google Patents

Novel galenical form for oral administration with prolonged release of molsidomine

Info

Publication number
AU4065301A
AU4065301A AU4065301A AU4065301A AU4065301A AU 4065301 A AU4065301 A AU 4065301A AU 4065301 A AU4065301 A AU 4065301A AU 4065301 A AU4065301 A AU 4065301A AU 4065301 A AU4065301 A AU 4065301A
Authority
AU
Australia
Prior art keywords
molsidomine
hours
released
angina
galenical form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4065301A
Other languages
English (en)
Inventor
Jozsef-Michel Geczy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Therabel Pharmaceuticals Ltd
Original Assignee
Therabel Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Pharmaceuticals Ltd filed Critical Therabel Pharmaceuticals Ltd
Publication of AU4065301A publication Critical patent/AU4065301A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU4065301A 2000-02-24 2001-02-22 Novel galenical form for oral administration with prolonged release of molsidomine Pending AU4065301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0002307A FR2805462B1 (fr) 2000-02-24 2000-02-24 Nouvelle forme galenique orale a liberation prolongee de la molsidomine
PCT/EP2001/002055 WO2001062256A1 (fr) 2000-02-24 2001-02-22 Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Publications (1)

Publication Number Publication Date
AU4065301A true AU4065301A (en) 2001-09-03

Family

ID=8847342

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4065301A Pending AU4065301A (en) 2000-02-24 2001-02-22 Novel galenical form for oral administration with prolonged release of molsidomine
AU2001240653A Expired AU2001240653B9 (en) 2000-02-24 2001-02-22 Novel galenical form for oral administration with prolonged release of molsidomine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001240653A Expired AU2001240653B9 (en) 2000-02-24 2001-02-22 Novel galenical form for oral administration with prolonged release of molsidomine

Country Status (36)

Country Link
US (1) US7767227B2 (ru)
EP (1) EP1265614B1 (ru)
JP (1) JP4945043B2 (ru)
KR (1) KR100814191B1 (ru)
CN (1) CN100396284C (ru)
AT (1) ATE296632T1 (ru)
AU (2) AU4065301A (ru)
BE (1) BE1013487A3 (ru)
BG (1) BG66111B1 (ru)
BR (1) BRPI0108041B8 (ru)
CA (1) CA2400886C (ru)
CZ (1) CZ301993B6 (ru)
DE (1) DE60111196T2 (ru)
DZ (1) DZ3273A1 (ru)
EE (1) EE05098B1 (ru)
ES (1) ES2241803T3 (ru)
FR (1) FR2805462B1 (ru)
HK (1) HK1050138B (ru)
HR (1) HRP20020692B1 (ru)
HU (1) HU229799B1 (ru)
IL (2) IL151205A0 (ru)
IS (1) IS2446B (ru)
MA (1) MA25576A1 (ru)
MD (1) MD3119C2 (ru)
MX (1) MXPA02008262A (ru)
NO (1) NO329495B1 (ru)
NZ (1) NZ520691A (ru)
OA (1) OA12183A (ru)
PL (1) PL201631B1 (ru)
PT (1) PT1265614E (ru)
RS (1) RS50291B (ru)
RU (1) RU2263506C2 (ru)
SK (1) SK286313B6 (ru)
UA (1) UA73972C2 (ru)
WO (1) WO2001062256A1 (ru)
ZA (1) ZA200206042B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
FR2868314B1 (fr) * 2004-04-05 2008-10-24 Therabel Pharmaceuticals Ltd Nouvelle utilisation therapeutique de la molsidomine et de ses sels pharmaceutiquement acceptables
EP2468269A1 (en) 2010-11-26 2012-06-27 Universitätsklinikum Münster Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
CN1006522B (zh) * 1986-04-30 1990-01-24 田道制药有限公司 缓放性制剂的制备方法
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
DE59408793D1 (de) * 1993-05-11 1999-11-11 Hoechst Ag Galenische Zubereitungen von Molsidomin
EP0707465A4 (en) * 1993-07-08 1997-04-16 Cygnus Therapeutic Systems MONOLITHIC MATRIX TRANSDERMAL DELIVERY SYSTEM
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE4443105C2 (de) * 1994-12-03 1997-03-13 Hoechst Ag Verfahren zur Herstellung Molsidomin-haltiger Tabletten
JPH09114680A (ja) * 1995-10-19 1997-05-02 Fuji Xerox Co Ltd シーケンス制御装置
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
DE69828635T2 (de) * 1997-09-19 2005-06-16 Shire Laboratories, Inc. Feste lösungskügelchen
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Also Published As

Publication number Publication date
UA73972C2 (en) 2005-10-17
RU2263506C2 (ru) 2005-11-10
DE60111196D1 (de) 2005-07-07
WO2001062256A1 (fr) 2001-08-30
CA2400886C (fr) 2011-04-19
PL201631B1 (pl) 2009-04-30
HK1050138B (zh) 2005-07-29
IS2446B (is) 2008-11-15
DZ3273A1 (fr) 2001-08-30
SK12202002A3 (sk) 2002-12-03
FR2805462A1 (fr) 2001-08-31
HRP20020692A2 (en) 2004-02-29
JP4945043B2 (ja) 2012-06-06
MD3119B2 (en) 2006-08-31
HRP20020692B1 (en) 2011-10-31
OA12183A (fr) 2006-05-09
CN1419451A (zh) 2003-05-21
EP1265614A1 (fr) 2002-12-18
NZ520691A (en) 2004-07-30
SK286313B6 (en) 2008-07-07
IL151205A (en) 2011-01-31
KR100814191B1 (ko) 2008-03-17
DE60111196T2 (de) 2006-05-11
HUP0300607A3 (en) 2006-02-28
NO20024043D0 (no) 2002-08-23
JP2003523981A (ja) 2003-08-12
HU229799B1 (en) 2014-07-28
EE05098B1 (et) 2008-12-15
BG107027A (bg) 2003-04-30
FR2805462B1 (fr) 2003-08-15
IS6504A (is) 2002-08-14
YU62202A (sh) 2006-01-16
AU2001240653B9 (en) 2005-10-27
CZ301993B6 (cs) 2010-09-01
CN100396284C (zh) 2008-06-25
ZA200206042B (en) 2003-07-29
PT1265614E (pt) 2005-10-31
IL151205A0 (en) 2003-04-10
EP1265614B1 (fr) 2005-06-01
MD3119C2 (ru) 2007-04-30
HUP0300607A2 (hu) 2003-08-28
NO329495B1 (no) 2010-11-01
KR20020081323A (ko) 2002-10-26
CA2400886A1 (fr) 2001-08-30
MD20020212A (en) 2002-12-31
ES2241803T3 (es) 2005-11-01
BE1013487A3 (fr) 2002-02-05
BG66111B1 (bg) 2011-05-31
EE200200472A (et) 2003-12-15
BR0108041A (pt) 2002-10-29
RU2002121503A (ru) 2004-03-20
BR0108041B1 (pt) 2013-06-18
MA25576A1 (fr) 2002-10-01
NO20024043L (no) 2002-08-23
HK1050138A1 (en) 2003-06-13
US20030045522A1 (en) 2003-03-06
MXPA02008262A (es) 2004-04-05
PL357550A1 (en) 2004-07-26
US7767227B2 (en) 2010-08-03
ATE296632T1 (de) 2005-06-15
RS50291B (sr) 2009-09-08
BRPI0108041B8 (pt) 2021-05-25
AU2001240653B2 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
RS115104A (en) Pramipexole once-daily dosage form
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
ATE333265T1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
CA2476201A1 (en) Modified release formulations of at least one form of tramadol
JO2555B1 (en) Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
HUP0302086A2 (hu) Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására
MY126555A (en) Oral pharmaceutical extended release dosage form
EA200870368A1 (ru) Антибиотические композиции с модифицированным высвобождением и способ их получения
GB2395434A (en) Composition for reducing appetite in mammals comprising proxyanidin
WO2007010559A3 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
HRP20020692A2 (en) Novel galenical form for oral administration with prolonged release of molsidomine
JP2004522780A5 (ru)
HUP0401021A2 (hu) Gepiront tartalmazó gyógyászati készítmény orális beadásra
HRP20160479T1 (hr) Oralni pripravak molsidomina s produljenim otpuštanjem, namijenjen liječenju ateroskleroze
IT1293835B1 (it) Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione